Kinnate Biopharma, Inc. (KNTE)
NASDAQ: KNTE · IEX Real-Time Price · USD
12.62
-0.38 (-2.92%)
Jun 29, 2022 4:00 PM EDT - Market closed
Income Statement (Annual)
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Year | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|
| Selling, General & Admin
|
22.95 | 6.76 | 3.06 | 1.96 |
| Research & Development
|
67.17 | 29.24 | 8.96 | 5.68 |
| Operating Expenses
|
90.11 | 36 | 12.01 | 7.63 |
| Operating Income
|
-90.11 | -36 | -12.01 | -7.63 |
| Other Expense / Income
|
-0.35 | -0.24 | -0.04 | 0 |
| Pretax Income
|
-89.76 | -35.76 | -11.97 | -7.63 |
| Net Income
|
-89.76 | -35.76 | -11.97 | -7.63 |
| Preferred Dividends
|
0 | 0 | -2.03 | 0 |
| Net Income Common
|
-89.76 | -35.76 | -9.94 | -7.63 |
| Shares Outstanding (Basic)
|
44 | 7 | 4 | 4 |
| Shares Outstanding (Diluted)
|
44 | 7 | 4 | 4 |
| Shares Change
|
544.26% | 84.93% | 0.30% | - |
| EPS (Basic)
|
-2.06 | -5.28 | -2.72 | -2.09 |
| EPS (Diluted)
|
-2.06 | -5.28 | -2.72 | -2.09 |
| Free Cash Flow Per Share
|
-1.65 | -4.50 | -2.88 | -2.25 |
| EBITDA
|
-89.64 | -35.68 | -11.97 | -7.63 |
| Depreciation & Amortization
|
0.12 | 0.08 | 0 | 0 |
| EBIT
|
-89.76 | -35.76 | -11.97 | -7.63 |
Source: Financials are provided by
Nasdaq Data Link
and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).